Your browser doesn't support javascript.
loading
Re: Christian Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72.
Eur Urol ; 55(4): e72-3; author reply e74-5, 2009 Apr.
Article in En | MEDLINE | ID: mdl-18718705

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteonecrosis / Prostatic Neoplasms / Jaw Diseases / Diphosphonates / Bone Density Conservation Agents / Imidazoles Type of study: Etiology_studies / Prevalence_studies Limits: Humans / Male Language: En Journal: Eur Urol Year: 2009 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteonecrosis / Prostatic Neoplasms / Jaw Diseases / Diphosphonates / Bone Density Conservation Agents / Imidazoles Type of study: Etiology_studies / Prevalence_studies Limits: Humans / Male Language: En Journal: Eur Urol Year: 2009 Document type: Article